Logo
I

InterVenn Biosciences

186 employees

InterVenn unlocks the glycoproteome using artificial intelligence for the development of transformational healthcare solutions in DX and Rx.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Artificial Intelligence
Life Science
proteomics
mass spectrometry
artificial intelligence
Health Care
glycoproteomics
epiproteomics
LC-MS
Medical
biotech

Date founded

2017

Funding rounds raised

Total raised

$201M

from 18 investors over 18 rounds

I

InterVenn Biosciences raised $201M on August 2, 2021

Investors: Amplify Partners, Heritage Physician Networks, True Ventures, Anzu Partners, Irving Investors and Genoa Ventures

I

InterVenn Biosciences raised $34M on November 16, 2020

Investors: Amplify Partners, Anzu Partners, Xeraya Capital, True Ventures and Genoa Ventures

I

InterVenn Biosciences raised $9.4M on December 12, 2018

Investors: Amplify Partners, PradoSV, Boost VC, Genoa Ventures and True Ventures

I

InterVenn Biosciences raised undisclosed on April 1, 2017

Investors: Matadero Capital and Boost VC

FAQ